Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Björkbacka H[au]:

Atherosclerosis: cell biology and lipoproteins. Bengtsson E et al. Curr Opin Lipidol. (2016)

Altered metabolism distinguishes high-risk from stable carotid atherosclerotic plaques. Tomas L et al. Eur Heart J. (2018)

Atherosclerosis: cell biology and lipoproteins. Björkbacka H et al. Curr Opin Lipidol. (2015)

Search results

Items: 1 to 50 of 100

1.

ILC2 transfers to apolipoprotein E deficient mice reduce the lipid content of atherosclerotic lesions.

Mantani PT, Dunér P, Ljungcrantz I, Nilsson J, Björkbacka H, Fredrikson GN.

BMC Immunol. 2019 Dec 10;20(1):47. doi: 10.1186/s12865-019-0330-z.

2.

Low Levels of CD4+CD28null T Cells at Baseline Are Associated With First-Time Coronary Events in a Prospective Population-Based Case-Control Cohort.

Tomas L, Bengtsson E, Andersson L, Badn W, Tengryd C, Persson A, Edsfeldt A, Nilsson PM, Schiopu A, Nilsson J, Gonçalves I, Björkbacka H.

Arterioscler Thromb Vasc Biol. 2019 Dec 5:ATVBAHA119313032. doi: 10.1161/ATVBAHA.119.313032. [Epub ahead of print]

PMID:
31801374
3.

Cartilage Oligomeric Matrix Protein Associates With a Vulnerable Plaque Phenotype in Human Atherosclerotic Plaques.

Hultman K, Edsfeldt A, Björkbacka H, Dunér P, Sundius L, Nitulescu M, Persson A, Boyle JJ, Nilsson J, Hultgårdh-Nilsson A, Bengtsson E, Gonçalves I.

Stroke. 2019 Nov;50(11):3289-3292. doi: 10.1161/STROKEAHA.119.026457. Epub 2019 Sep 9.

PMID:
31495329
4.

Circulating Monocyte Chemoattractant Protein-1 and Risk of Stroke: Meta-Analysis of Population-Based Studies Involving 17 180 Individuals.

Georgakis MK, Malik R, Björkbacka H, Pana TA, Demissie S, Ayers C, Elhadad MA, Fornage M, Beiser AS, Benjamin EJ, Boekholdt MS, Engström G, Herder C, Hoogeveen RC, Koenig W, Melander O, Orho-Melander M, Schiopu A, Söderholm M, Wareham N, Ballantyne CM, Peters A, Seshadri S, Myint PK, Nilsson J, de Lemos JA, Dichgans M.

Circ Res. 2019 Sep 27;125(8):773-782. doi: 10.1161/CIRCRESAHA.119.315380. Epub 2019 Sep 3.

PMID:
31476962
5.

Lack of Ability to Present Antigens on Major Histocompatibility Complex Class II Molecules Aggravates Atherosclerosis in ApoE-/- Mice.

Wigren M, Rattik S, Yao Mattisson I, Tomas L, Grönberg C, Söderberg I, Alm R, Sundius L, Ljungcrantz I, Björkbacka H, Fredrikson GN, Nilsson J.

Circulation. 2019 May 28;139(22):2554-2566. doi: 10.1161/CIRCULATIONAHA.118.039288. Epub 2019 Apr 30.

PMID:
31136220
6.

High Levels of Soluble Lectinlike Oxidized Low-Density Lipoprotein Receptor-1 Are Associated With Carotid Plaque Inflammation and Increased Risk of Ischemic Stroke.

Markstad H, Edsfeldt A, Yao Mattison I, Bengtsson E, Singh P, Cavalera M, Asciutto G, Björkbacka H, Fredrikson GN, Dias N, Volkov P, Orho-Melander M, Nilsson J, Engström G, Gonçalves I.

J Am Heart Assoc. 2019 Feb 19;8(4):e009874. doi: 10.1161/JAHA.118.009874.

7.

Atherosclerosis: cell biology and lipoproteins.

Engelbertsen D, Rattik S, Björkbacka H.

Curr Opin Lipidol. 2019 Feb;30(1):50-52. doi: 10.1097/MOL.0000000000000562. No abstract available.

PMID:
30585935
8.

Elevated circulating effector memory T cells but similar levels of regulatory T cells in patients with type 2 diabetes mellitus and cardiovascular disease.

Rattik S, Engelbertsen D, Wigren M, Ljungcrantz I, Östling G, Persson M, Nordin Fredrikson G, Bengtsson E, Nilsson J, Björkbacka H.

Diab Vasc Dis Res. 2019 May;16(3):270-280. doi: 10.1177/1479164118817942. Epub 2018 Dec 21.

PMID:
30574794
9.

B cells treated with CTB-p210 acquire a regulatory phenotype in vitro and reduce atherosclerosis in apolipoprotein E deficient mice.

Rattik S, Mantani PT, Yao Mattisson I, Ljungcrantz I, Sundius L, Björkbacka H, Terrinoni M, Lebens M, Holmgren J, Nilsson J, Wigren M, Nordin Fredrikson G.

Vascul Pharmacol. 2018 Dec;111:54-61. doi: 10.1016/j.vph.2018.09.002. Epub 2018 Sep 19.

PMID:
30243560
10.

IL-16/miR-125a axis controls neutrophil recruitment in pristane-induced lung inflammation.

Smith S, Wu PW, Seo JJ, Fernando T, Jin M, Contreras J, Montano EN, Gabhann JN, Cunningham K, Widaa A, McCarthy EM, Molloy ES, Kearns G, Murphy CC, Kong W, Björkbacka H, Kornfeld H, Forbess L, Venuturupalli S, Ishimori M, Wallace D, Weisman MH, Jefferies CA.

JCI Insight. 2018 Aug 9;3(15). pii: 120798. doi: 10.1172/jci.insight.120798. eCollection 2018 Aug 9.

11.

Use of Vascular Assessments and Novel Biomarkers to Predict Cardiovascular Events in Type 2 Diabetes: The SUMMIT VIP Study.

Shore AC, Colhoun HM, Natali A, Palombo C, Khan F, Östling G, Aizawa K, Kennbäck C, Casanova F, Persson M, Gooding K, Gates PE, Looker H, Dove F, Belch J, Pinnola S, Venturi E, Kozakova M, Goncalves I, Kravic J, Björkbacka H, Nilsson J; SUMMIT Consortium.

Diabetes Care. 2018 Oct;41(10):2212-2219. doi: 10.2337/dc18-0185. Epub 2018 Jul 30.

12.

Interleukin-25 reduces Th17 cells and inflammatory responses in human peripheral blood mononuclear cells.

Mantani PT, Vallejo J, Ljungcrantz I, Nilsson J, Björkbacka H, Fredrikson GN.

Hum Immunol. 2018 Sep;79(9):685-692. doi: 10.1016/j.humimm.2018.06.008. Epub 2018 Jul 4.

PMID:
29966691
13.

Interleukin-25 (IL-25) has a protective role in atherosclerosis development in the aortic arch in mice.

Mantani PT, Dunér P, Bengtsson E, Ljungcrantz I, Sundius L, To F, Nilsson J, Björkbacka H, Fredrikson GN.

J Biol Chem. 2018 May 4;293(18):6791-6801. doi: 10.1074/jbc.RA117.000292. Epub 2018 Mar 23.

14.

Altered metabolism distinguishes high-risk from stable carotid atherosclerotic plaques.

Tomas L, Edsfeldt A, Mollet IG, Perisic Matic L, Prehn C, Adamski J, Paulsson-Berne G, Hedin U, Nilsson J, Bengtsson E, Gonçalves I, Björkbacka H.

Eur Heart J. 2018 Jun 21;39(24):2301-2310. doi: 10.1093/eurheartj/ehy124.

15.

Elevated Markers of Death Receptor-Activated Apoptosis are Associated with Increased Risk for Development of Diabetes and Cardiovascular Disease.

Mattisson IY, Björkbacka H, Wigren M, Edsfeldt A, Melander O, Fredrikson GN, Bengtsson E, Gonçalves I, Orho-Melander M, Engström G, Almgren P, Nilsson J.

EBioMedicine. 2017 Dec;26:187-197. doi: 10.1016/j.ebiom.2017.11.023. Epub 2017 Nov 24. No abstract available.

16.

IL-1R and MyD88 signalling in CD4+ T cells promote Th17 immunity and atherosclerosis.

Engelbertsen D, Rattik S, Wigren M, Vallejo J, Marinkovic G, Schiopu A, Björkbacka H, Nilsson J, Bengtsson E.

Cardiovasc Res. 2018 Jan 1;114(1):180-187. doi: 10.1093/cvr/cvx196.

PMID:
29036304
17.

High Levels of (Un)Switched Memory B Cells Are Associated With Better Outcome in Patients With Advanced Atherosclerotic Disease.

Meeuwsen JAL, van Duijvenvoorde A, Gohar A, Kozma MO, van de Weg SM, Gijsberts CM, Haitjema S, Björkbacka H, Fredrikson GN, de Borst GJ, den Ruijter HM, Pasterkamp G, Binder CJ, Hoefer IE, de Jager SCA.

J Am Heart Assoc. 2017 Sep 7;6(9). pii: e005747. doi: 10.1161/JAHA.117.005747.

18.

Plasma stem cell factor levels are associated with risk of cardiovascular disease and death.

Björkbacka H, Yao Mattisson I, Wigren M, Melander O, Fredrikson GN, Bengtsson E, Gonçalves I, Almgren P, Lagerstedt JO, Orho-Melander M, Engström G, Nilsson J.

J Intern Med. 2017 Dec;282(6):508-521. doi: 10.1111/joim.12675. Epub 2017 Sep 21.

19.

Circulating GDF-15 levels predict future secondary manifestations of cardiovascular disease explicitly in women but not men with atherosclerosis.

Gohar A, Gonçalves I, Vrijenhoek J, Haitjema S, van Koeverden I, Nilsson J, de Borst GJ, de Vries JP, Pasterkamp G, den Ruijter HM, Björkbacka H, de Jager SCA.

Int J Cardiol. 2017 Aug 15;241:430-436. doi: 10.1016/j.ijcard.2017.03.101. Epub 2017 Mar 22.

20.

Associations Between Macrophage Colony-Stimulating Factor and Monocyte Chemotactic Protein 1 in Plasma and First-Time Coronary Events: A Nested Case-Control Study.

Schiopu A, Bengtsson E, Gonçalves I, Nilsson J, Fredrikson GN, Björkbacka H.

J Am Heart Assoc. 2016 Sep 13;5(9). pii: e002851. doi: 10.1161/JAHA.115.002851.

21.

Association between renin and atherosclerotic burden in subjects with and without type 2 diabetes.

Gonçalves I, Edsfeldt A, Colhoun HM, Shore AC, Palombo C, Natali A, Fredrikson GN, Björkbacka H, Wigren M, Bengtsson E, Östling G, Aizawa K, Casanova F, Persson M, Gooding K, Gates P, Khan F, Looker HC, Adams F, Belch J, Pinnola S, Venturi E, Kozakova M, Gan LM, Schnecke V, Nilsson J; SUMMIT consortium.

BMC Cardiovasc Disord. 2016 Sep 5;16(1):171. doi: 10.1186/s12872-016-0346-8.

22.

Can Circulating Regulatory T Cells Predict Cardiovascular Disease?

Björkbacka H.

EBioMedicine. 2016 Sep;11:15-16. doi: 10.1016/j.ebiom.2016.08.044. Epub 2016 Aug 30. No abstract available.

23.

Endarterectomy patients with elevated levels of circulating IL-16 have fewer cardiovascular events during follow-up.

Grönberg C, Asciutto G, Persson A, Fredrikson GN, Nilsson J, Gonçalves I, Björkbacka H.

Cytokine. 2016 Sep;85:137-9. doi: 10.1016/j.cyto.2016.06.009. Epub 2016 Jun 22.

PMID:
27344024
24.

Apolipoprotein B-100 Antibody Interaction With Atherosclerotic Plaque Inflammation and Repair Processes.

Asciutto G, Wigren M, Fredrikson GN, Mattisson IY, Grönberg C, Alm R, Björkbacka H, Dias NV, Edsfeldt A, Gonçalves I, Nilsson J.

Stroke. 2016 Apr;47(4):1140-3. doi: 10.1161/STROKEAHA.116.012677. Epub 2016 Mar 10.

PMID:
26965851
25.

Low Levels of Apolipoprotein B-100 Autoantibodies Are Associated With Increased Risk of Coronary Events.

Björkbacka H, Alm R, Persson M, Hedblad B, Nilsson J, Fredrikson GN.

Arterioscler Thromb Vasc Biol. 2016 Apr;36(4):765-71. doi: 10.1161/ATVBAHA.115.306938. Epub 2016 Feb 25.

PMID:
26916732
26.

High levels of cathepsin D and cystatin B are associated with increased risk of coronary events.

Gonçalves I, Hultman K, Dunér P, Edsfeldt A, Hedblad B, Fredrikson GN, Björkbacka H, Nilsson J, Bengtsson E.

Open Heart. 2016 Jan 27;3(1):e000353. doi: 10.1136/openhrt-2015-000353. eCollection 2016.

27.

Genetic loci on chromosome 5 are associated with circulating levels of interleukin-5 and eosinophil count in a European population with high risk for cardiovascular disease.

McLeod O, Silveira A, Valdes-Marquez E, Björkbacka H, Almgren P, Gertow K, Gådin JR, Bäcklund A, Sennblad B, Baldassarre D, Veglia F, Humphries SE, Tremoli E, de Faire U, Nilsson J, Melander O, Hopewell JC, Clarke R, Björck HM, Hamsten A, Öhrvik J, Strawbridge RJ; IMPROVE Study Group.

Cytokine. 2016 May;81:1-9. doi: 10.1016/j.cyto.2016.01.007. Epub 2016 Jan 25.

28.

High Plasma Levels of Galectin-3 Are Associated with Increased Risk for Stroke after Carotid Endarterectomy.

Edsfeldt A, Bengtsson E, Asciutto G, Dunér P, Björkbacka H, Fredrikson GN, Nilsson J, Goncalves I.

Cerebrovasc Dis. 2016;41(3-4):199-203. doi: 10.1159/000443022. Epub 2016 Jan 27.

PMID:
26812165
29.

Atherosclerosis: cell biology and lipoproteins.

Bengtsson E, Björkbacka H.

Curr Opin Lipidol. 2016 Feb;27(1):94-6. doi: 10.1097/MOL.0000000000000267. No abstract available.

PMID:
26655288
30.

Decreased levels of stem cell factor in subjects with incident coronary events.

Wigren M, Rattik S, Hultman K, Björkbacka H, Nordin-Fredrikson G, Bengtsson E, Hedblad B, Siegbahn A, Gonçalves I, Nilsson J.

J Intern Med. 2016 Feb;279(2):180-91. doi: 10.1111/joim.12443. Epub 2015 Oct 14.

31.

Human Carotid Plaques With High Levels of Interleukin-16 Are Associated With Reduced Risk for Cardiovascular Events.

Grönberg C, Bengtsson E, Fredrikson GN, Nitulescu M, Asciutto G, Persson A, Andersson L, Nilsson J, Gonçalves I, Björkbacka H.

Stroke. 2015 Oct;46(10):2748-54. doi: 10.1161/STROKEAHA.115.009910. Epub 2015 Sep 1.

PMID:
26330445
32.

IL-22 affects smooth muscle cell phenotype and plaque formation in apolipoprotein E knockout mice.

Rattik S, Hultman K, Rauch U, Söderberg I, Sundius L, Ljungcrantz I, Hultgårdh-Nilsson A, Wigren M, Björkbacka H, Fredrikson GN, Nilsson J.

Atherosclerosis. 2015 Oct;242(2):506-14. doi: 10.1016/j.atherosclerosis.2015.08.006. Epub 2015 Aug 11.

PMID:
26298743
33.

Low Levels of IgM Antibodies against an Advanced Glycation Endproduct-Modified Apolipoprotein B100 Peptide Predict Cardiovascular Events in Nondiabetic Subjects.

Engelbertsen D, Vallejo J, Quách TD, Fredrikson GN, Alm R, Hedblad B, Björkbacka H, Rothstein TL, Nilsson J, Bengtsson E.

J Immunol. 2015 Oct 1;195(7):3020-5. doi: 10.4049/jimmunol.1402869. Epub 2015 Aug 19.

34.

CD4+ CD56+ natural killer T-like cells secreting interferon-γ are associated with incident coronary events.

Björkbacka H, Berg KE, Manjer J, Engelbertsen D, Wigren M, Ljungcrantz I, Andersson L, Hedblad B, Fredrikson GN, Nilsson J.

J Intern Med. 2016 Jan;279(1):78-88. doi: 10.1111/joim.12392. Epub 2015 Jul 3.

35.

Elevated Plasma Levels of MMP-12 Are Associated With Atherosclerotic Burden and Symptomatic Cardiovascular Disease in Subjects With Type 2 Diabetes.

Goncalves I, Bengtsson E, Colhoun HM, Shore AC, Palombo C, Natali A, Edsfeldt A, Dunér P, Fredrikson GN, Björkbacka H, Östling G, Aizawa K, Casanova F, Persson M, Gooding K, Strain D, Khan F, Looker HC, Adams F, Belch J, Pinnoli S, Venturi E, Kozakova M, Gan LM, Schnecke V, Nilsson J; SUMMIT Consortium.

Arterioscler Thromb Vasc Biol. 2015 Jul;35(7):1723-31. doi: 10.1161/ATVBAHA.115.305631. Epub 2015 May 7.

PMID:
25953645
36.

Duffy antigen receptor genetic variant and the association with Interleukin 8 levels.

Moreno Velásquez I, Kumar J, Björkbacka H, Nilsson J, Silveira A, Leander K, Berglund A, Strawbridge RJ, Ärnlöv J, Melander O, Almgren P, Lind L, Hamsten A, de Faire U, Gigante B.

Cytokine. 2015 Apr;72(2):178-84. doi: 10.1016/j.cyto.2014.12.019. Epub 2015 Jan 31.

PMID:
25647274
37.

IL-25 inhibits atherosclerosis development in apolipoprotein E deficient mice.

Mantani PT, Dunér P, Bengtsson E, Alm R, Ljungcrantz I, Söderberg I, Sundius L, To F, Nilsson J, Björkbacka H, Fredrikson GN.

PLoS One. 2015 Jan 28;10(1):e0117255. doi: 10.1371/journal.pone.0117255. eCollection 2015.

38.

Atherosclerosis: cell biology and lipoproteins.

Björkbacka H.

Curr Opin Lipidol. 2015 Feb;26(1):67-9. doi: 10.1097/MOL.0000000000000150. No abstract available.

PMID:
25551805
39.

A high quality diet is associated with reduced systemic inflammation in middle-aged individuals.

Dias JA, Wirfält E, Drake I, Gullberg B, Hedblad B, Persson M, Engström G, Nilsson J, Schiopu A, Fredrikson GN, Björkbacka H.

Atherosclerosis. 2015 Jan;238(1):38-44. doi: 10.1016/j.atherosclerosis.2014.11.006. Epub 2014 Nov 13.

PMID:
25437888
40.

High plasma levels of heparin-binding epidermal growth factor are associated with a more stable plaque phenotype and reduced incidence of coronary events.

Rattik S, Wigren M, Björkbacka H, Fredrikson GN, Hedblad B, Siegbahn A, Bengtsson E, Schiopu A, Edsfeldt A, Dunér P, Grufman H, Gonçalves I, Nilsson J.

Arterioscler Thromb Vasc Biol. 2015 Jan;35(1):222-8. doi: 10.1161/ATVBAHA.114.304369. Epub 2014 Oct 30.

PMID:
25359857
41.

Evidence for altered inflammatory and repair responses in symptomatic carotid plaques from elderly patients.

Grufman H, Schiopu A, Edsfeldt A, Björkbacka H, Nitulescu M, Nilsson M, Persson A, Nilsson J, Gonçalves I.

Atherosclerosis. 2014 Nov;237(1):177-82. doi: 10.1016/j.atherosclerosis.2014.08.042. Epub 2014 Sep 6.

PMID:
25240113
42.

Impaired fibrous repair: a possible contributor to atherosclerotic plaque vulnerability in patients with type II diabetes.

Edsfeldt A, Gonçalves I, Grufman H, Nitulescu M, Dunér P, Bengtsson E, Mollet IG, Persson A, Nilsson M, Orho-Melander M, Melander O, Björkbacka H, Nilsson J.

Arterioscler Thromb Vasc Biol. 2014 Sep;34(9):2143-50. doi: 10.1161/ATVBAHA.114.303414. Epub 2014 Jul 17.

PMID:
25035341
43.

Atherosclerosis: cell biology and lipoproteins.

Björkbacka H.

Curr Opin Lipidol. 2014 Aug;25(4):319-20. doi: 10.1097/MOL.0000000000000101. No abstract available.

PMID:
25003740
44.

Induction of T helper 2 responses against human apolipoprotein B100 does not affect atherosclerosis in ApoE-/- mice.

Engelbertsen D, Rattik S, Knutsson A, Björkbacka H, Bengtsson E, Nilsson J.

Cardiovasc Res. 2014 Jul 15;103(2):304-12. doi: 10.1093/cvr/cvu131. Epub 2014 May 27.

PMID:
24866382
45.

Is Toll-like receptor responsiveness a marker and predictor of coronary artery disease?

Björkbacka H.

Atherosclerosis. 2014 Jan;232(1):197-8. doi: 10.1016/j.atherosclerosis.2013.11.032. Epub 2013 Nov 20. No abstract available.

PMID:
24401237
46.

Circulating CD40+ and CD86+ B cell subsets demonstrate opposing associations with risk of stroke.

Mantani PT, Ljungcrantz I, Andersson L, Alm R, Hedblad B, Björkbacka H, Nilsson J, Fredrikson GN.

Arterioscler Thromb Vasc Biol. 2014 Jan;34(1):211-8. doi: 10.1161/ATVBAHA.113.302667. Epub 2013 Nov 7.

PMID:
24202305
47.

Plasma S100A8/A9 correlates with blood neutrophil counts, traditional risk factors, and cardiovascular disease in middle-aged healthy individuals.

Cotoi OS, Dunér P, Ko N, Hedblad B, Nilsson J, Björkbacka H, Schiopu A.

Arterioscler Thromb Vasc Biol. 2014 Jan;34(1):202-10. doi: 10.1161/ATVBAHA.113.302432. Epub 2013 Nov 7.

PMID:
24202303
48.

Atherosclerosis: cell biology and lipoproteins.

Björkbacka H.

Curr Opin Lipidol. 2013 Jun;24(3):279-80. doi: 10.1097/MOL.0b013e328361632b. No abstract available.

PMID:
23652474
49.

Association between CD8+ T-cell subsets and cardiovascular disease.

Kolbus D, Ljungcrantz I, Andersson L, Hedblad B, Fredrikson GN, Björkbacka H, Nilsson J.

J Intern Med. 2013 Jul;274(1):41-51. doi: 10.1111/joim.12038. Epub 2013 Feb 22.

50.

T-helper 2 immunity is associated with reduced risk of myocardial infarction and stroke.

Engelbertsen D, Andersson L, Ljungcrantz I, Wigren M, Hedblad B, Nilsson J, Björkbacka H.

Arterioscler Thromb Vasc Biol. 2013 Mar;33(3):637-44. doi: 10.1161/ATVBAHA.112.300871. Epub 2013 Jan 10.

PMID:
23307873

Supplemental Content

Loading ...
Support Center